Clinical trial
Pioglitazone in Impaired Glucose Tolerance
NCT00306826 · University of Leipzig, Other · Withdrawn
Key facts
| NCT number | NCT00306826 |
|---|---|
| Title | Pioglitazone in Impaired Glucose Tolerance |
| Official title | Effect of Pioglitazone on Intima Media Thickness, Endothelial Function, and Heart Rate Variability in Patients With Impaired Glucose Tolerance |
| Lead sponsor | University of Leipzig, Other |
| Collaborators | Institut für Gesundheits- und Praxismanagement GmbH |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glucose Metabolism Disorders |
| Intervention type | Drug |
| Interventions | pioglitazone, simvastatin, pioglitazone + simvastatin |
| Enrollment | 120 |
| Completion | May 1, 2009 |
| First posted | Mar 24, 2006 |
| Last update posted | Feb 2, 2010 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: